What is Crinetics Pharmaceuticals's R&D?

Crinetics Pharmaceuticals (CRNX) reported R&D of $100.08M in Q1 2026.

How has Crinetics Pharmaceuticals's R&D changed year-over-year?

Crinetics Pharmaceuticals's R&D increased by 31.3% year-over-year, from $76.24M to $100.08M.

What is the long-term trend for Crinetics Pharmaceuticals's R&D?

Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's R&D has grown at a 40.9% compound annual growth rate (CAGR), from $84.26M to $332.06M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Crinetics Pharmaceuticals CRNX R&D

R&D at other companies

Neurocrine BiosciencesNBIX

$296.2M+12.5%

Corcept TherapeuticsCORT

$66.27M+9.1%

Viking TherapeuticsVKTX

$150.15M+263%

Catalyst PharmaceuticalCPRX

$2.66M-31.5%

Ultragenyx PharmaceuticalRARE

$187M+12.7%

United TherapeuticsUTHR

$138.2M-7.2%

Segments

By segment

See full

Reportable Segment$100.08M+31.3%

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.79B+21.9%

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's R&D?: Crinetics Pharmaceuticals (CRNX) reported R&D of $100.08M in Q1 2026.
How has Crinetics Pharmaceuticals's R&D changed year-over-year?: Crinetics Pharmaceuticals's R&D increased by 31.3% year-over-year, from $76.24M to $100.08M.
What is the long-term trend for Crinetics Pharmaceuticals's R&D?: Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's R&D has grown at a 40.9% compound annual growth rate (CAGR), from $84.26M to $332.06M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.